Cerebral venous thrombosis in adolescence: Looking beyond the obvious

Sara Madureira Gomes1, Rita Figueiredo2, Ricardo Morais2, Sérgia Soares3, Jacinta Fonseca4, Cláudia Melo4, Mafalda Sampaio4, Raquel Sousa4
1Department of Pediatrics, Centro Hospitalar Universitário São João, Porto, Portugal
2Department of Neuroradiology, Centro Hospitalar Universitário São João, Porto, Portugal
3Department of Pediatrics, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Senhora da Hora, Portugal
4Pediatric Neurology Unit, Centro Hospitalar Universitário São João, Porto, Portugal

Tài liệu tham khảo

Alkan, 2019, Neuro-Behçet disease presented with pachymeningitis in a child, Arch Argent Pediatr, 117, E644 Yildiz, 20218, Pediatric Behçet’s disease, Front Med, 1 Costagliola, 2020, Behçet’s disease in children: diagnostic and management challenges, Therapeut Clin Risk Manag, 16, 495, 10.2147/TCRM.S232660 Mora, 2013, Neuro-Behçet’s disease in childhood: a focus on the neuro-ophthalmological features, Orphanet J Rare Dis, 8, 1, 10.1186/1750-1172-8-18 Koné-Paut, 2016, Consensus classification criteria for paediatric Behçet’s disease from a prospective observational cohort: PEDBD, Ann Rheum Dis, 75, 958, 10.1136/annrheumdis-2015-208491 Metreau-Vastel, 2010, Neurological involvement in paediatric behet's disease, Neuropediatrics, 41, 228, 10.1055/s-0030-1269909 Demir, 2019, Paediatric Behçet’s disease with sinus venous thrombosis: experience from three centres in Turkey, Clin Exp Rheumatol, 37, 147 Seyahi, 2011, Behçet’s syndrome and thrombosis, Mediterr J Hematol Infect Dis, 3, 10.4084/mjhid.2011.026 Kötter, 20218, Behçet‘s syndrome apart from the triple symptom complex: vascular, neurologic, gastrointestinal, and musculoskeletal manifestations. A mini review, Front Med, 1 Zhang, 202112, Characteristics and management of autoimmune disease-associated cerebral venous sinus thrombosis, Front Immunol, 10 De Sousa, 2011, Cerebral venous thrombosis in Behçet’s disease: a systematic review, J Neurol, 258, 719 Uluduz, 2019, Behçet’s disease as a causative factor of cerebral venous sinus thrombosis: subgroup analysis of data from the VENOST study, Rheumatol (United Kingdom), 58, 600 Adler, 2012, Behçet’s disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis, Arthritis Care Res, 64, 607, 10.1002/acr.21557 Kanemaru, 2013, Case of neuro-Behçet’s disease successfully maintained a remission using infliximab for 2 years, J Dermatol, 40, 632, 10.1111/1346-8138.12203 Borhani Haghighi, 2011, Infliximab for patients with neuro-Behcet’s disease: case series and literature review, Clin Rheumatol, 30, 1007, 10.1007/s10067-011-1726-1